Kineticos’ Operating Executive Steve Buckanavage, continues his discussion with Christopher Heery, M.D., CMO at Precision Biosciences as they tackle the

As we continue our discussion between Steve Buckanavage, Kineticos’ Operating Executive and Christopher Heery, M.D., CMO at Precision Biosciences, we

Throughout September and October, we have been discussing Precision Medicine and it’s impact on various segments of the life sciences.

Shailesh and Alan finish their discussion with how there were speculation that precision medicine would reduce innovation in pharma. See

Shailesh and Alan continue their discussion on companion diagnostics and start thinking about how AI and Machine Learning are impacting

Moving on from our Precision Medicine in Neurosciences, Kineticos’ Founder and CEO, Shailesh Maingi, talks with a diagnostics expert on

Closing out our Precision Medicine in Neurosciences discussion, Nik and Jason discuss how various partnerships can impact the success of

Continuing our Precision Medicine in Neuroscience discussion, Jason Kralic and Nik Tezapsidis discuss how biomarkers and partnerships will drive precision

In September, we turn our focus onto Precision Medicine and its impact on the life sciences. Kineticos held 3 conversations

As we close out our month long discussion on Alzheimer’s, Kineticos’ SVP of Biopharma, Kevin Hampton, leads our expert panelists